Literature DB >> 4205889

Intensive monitoring for adverse drug effects in patients discharged from acute medical wards.

G S Kellaway, E McCrae.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4205889

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


× No keyword cloud information.
  16 in total

1.  Information technology and medication safety: what is the benefit?

Authors:  R Kaushal; D W Bates
Journal:  Qual Saf Health Care       Date:  2002-09

Review 2.  Adverse reactions as a cause of hospital admission in the aged.

Authors:  K Beard
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

3.  Methodology and results of a survey of adverse reactons to a drug in private practice.

Authors:  A Spriet; C Spriet; C Larousse; D Chigot; M Roux; P Simon
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

Review 4.  Polypharmacy: the cure becomes the disease.

Authors:  C A Colley; L M Lucas
Journal:  J Gen Intern Med       Date:  1993-05       Impact factor: 5.128

Review 5.  Prescribing CNS drugs for elderly patients.

Authors:  K Ghose
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

6.  Adverse reactions to drugs in general practice.

Authors:  C R Martys
Journal:  Br Med J       Date:  1979-11-10

7.  Difficulties in assessing the adverse effects of drugs.

Authors:  M S Kramer
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

8.  Monitoring adverse reactions to antibiotics in general practice.

Authors:  C R Martys
Journal:  J Epidemiol Community Health       Date:  1982-09       Impact factor: 3.710

Review 9.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 10.  Adverse drug reactions. An overview of special considerations in the management of the elderly patient.

Authors:  L A Brawn; C M Castleden
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.